PATENT CLAIM ANALYSIS

Application Number: 16031250
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "360000"]

Abstract:
Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided.

Claim (Index 46):
The method according to  claim 35  wherein said mental disorder is schizophrenia.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.67391
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14278573', '11399188', '11591244', '13887901', '14022804']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7896161524578751
- 35 USC 102 Novelty (BERT): 0.5641313180364582
- Combined Prediction Score: 0.7670676690157334
- Mean Citation Score: 389.055668
- Max Citation Score: 599.818
- Similarity Product: 299.40959904259444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test